This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1933719107312681v1 15/6/552    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kim, D.-c. Articles by Cho, C.-H. Search for Related Content PubMed PubMed Citation Articles by Kim, D.-c. Articles by Sabarish, R. Articles by Baek, S.-h. Articles by Kwon, S.-H. Articles by Kwon, K.-Y. Articles by Cha, S.-D. Articles by Bae, I. Articles by Cho, C.-H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Uterine Cancer Uterine Fibroids Social Bookmarking                         What's this?

Induction of Growth Inhibition and Apoptosis in Human Uterine Leiomyoma Cells by Isoliquiritigenin

¹ Daegu Hanny University
² Keimyung University, School of Medicine
³ School of Medicine, Keimyung University
⁴ Georgetown University

^* To whom correspondence should be addressed. E-mail: chcho{at}kmu.ac.kr.

	Abstract

Isoliquiritigenin(ISL), a calchone flavonoid, has cancer-preventing properties and is often used in Chinese medicine. In the present study, the authors use ISL to determine its effect on cell proliferation and cell cycle progression in primary cultured human uterine leiomyoma cells. Cell viability and cell proliferation assays were conducted. Flow cytometry, annexin V apoptosis assay, and DNA fragmentation assay were performed to determine the effect of ISL on cell cycle and apoptosis. The expression of cell cycle regulatory–related proteins was evaluated by Western blot. The cell viability and proliferation of uterine leiomyoma cells were significantly reduced by ISL treatment in a dose-dependent manner. Flow cytometry results showed that ISL induced subG1 and G2/M arrest. DNA fragmentation assay and annexin V apoptosis assays revealed apoptosis induction. ISL-induced growth inhibition in uterine leiomyoma cells was associated with increased p21^{Cip1/ Waf1} expression in a p53-dependent manner. Activation of caspase-3 and downregulation of Bcl-2, cdk 2/4, and E2F, with a concomitant increase in dephosphorylation of Rb and poly–ADP-ribose polymerase cleavage, were observed. This study demonstrates that ISL inhibits cell proliferation by initiating apoptosis in human uterine leiomyoma cells coupled with increased cell cycle arrest. These results indicate that ISL could prove to be a promising chemopreventive and therapeutic agent against human uterine leiomyoma.

First published on May 16, 2008, doi:10.1177/1933719107312681

Reproductive Sciences 2008;15:552.

A more recent version of this article appeared on July 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?